Pharmacogenomics may be one of the most important current discoveries in medicine and is the study of the role of the genome in drug response.
The name reflects its combining of pharmacology and genomics.
Pharmacogenomics analyzes how the genetic makeup of an individual affects their response to drugs.
It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets).
The term pharmacogenomics is often used interchangeably with pharmacogenetics.
Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.
Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects.
Through the utilization of pharmacogenomics, it is hoped that pharmaceutical drug treatments can deviate from what is dubbed as the one-dose-fits-all approach.
Pharmacogenomics also attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient's genes, the functionality of these genes, and how this may affect the efficacy of the patient's current or future treatments.
Such approaches promise the advent of precision medicine and even personalized medicine, in which drugs and drug combinations are optimized for narrow subsets of patients or even for each individual's unique genetic makeup.
This book is designed to be a state of the art, superb academic reference work and provide an overview of the topic and give the reader a struct.
Platforma de publicare independentă CreateSpace a fost un serviciu de autopublicare pentru autori independenți, cunoscut în primul rând pentru că îi ajută pe autori să publice și să distribuie cărți tipărite la cerere.
CreateSpace și-a schimbat serviciile la Kindle Direct Publishing (KDP).
CreateSpace și KDP fac ambele parte din platformele de autopublicare ale Amazon, iar autorii pot folosi KDP pentru a publica și distribui atât cărți electronice, cât și cărți tipărite.
Prin KDP, autorii își pot crea, publica și distribui cărțile la nivel global, ajungând la cititori prin rețeaua vastă a Amazon.
Dacă sunteți autor sau aspiră să publice o carte, poate doriți să explorați Kindle Direct Publishing (KDP) pentru nevoile dvs.
de autopublicare.
Createspace Independent Publishing Platform Pharmacogenomics: the use of genetics in prescribing medications, paperback/edited by paul f. kisak
